Symbol Surfing makes it fast & easy to find your next great idea. Just select a channel to get started.
The 52 Week Low is $99.91 set on Fri, Aug 21, 2020. The current price, $182.50, is 83% above the 52 Week Low.
The 52 Week High is $187.45 set on Wed, Jul 14, 2021.
The All-Time High is $208.88 set on Thu, Jul 23, 2015.
Alexion Pharmaceuticals trades on the NASDAQ. ALXN's market cap is 40.3 Billion.
Alexion Pharmaceuticals specializes in developing and marketing drugs for rare, life-threatening medical conditions. Its blockbuster product, Soliris, is approved for paroxysmal nocturnal hemoglobinuria (PNH), atypical hemolytic uremic syndrome (aHUS), generalized myasthenia gravis (gMG), and neuromyelitis optica spectrum disorder (NMOSD). Next-generation Ultomiris is approved in PNH and aHUS. Strensiq and Kanuma target ultrarare metabolic diseases. Alexion's pipeline targets rare diseases with high unmet need in hematology, nephrology, metabolic diseases, neurology, cardiology, and other areas.